- by Appala Naidu Kotana, Atanu K. MohantyEuropean Journal of Mass Spectrometry, Volume 31, Issue 5-6, Page 147-160, October–December 2025. In this study, an analytical approximation that can be used to estimate the change in the electric field caused by the introduction of circular slits on endcap electrodes of toroidal ion trap mass analysers will be developed. A theory has been developed …
- by Po-Tsun Shen, Shu Chih Liu, Ming-Chyi Huang, Yu-Li LiuEuropean Journal of Mass Spectrometry, Volume 31, Issue 5-6, Page 161-168, October–December 2025. Naltrexone, an FDA-approved mu-opioid receptor antagonist for alcohol dependence, requires therapeutic drug monitoring due to its pharmacokinetic variability. This study developed a liquid chromatography-electrospray ionization-tandem mass spectrometry …
- by Prachi Thukral, M V Jagadish, Priyanka Yadav, Salvi Jatan, Mayukh Chain, Mukesh K Singh, Shubham YadavEuropean Journal of Mass Spectrometry, Volume 31, Issue 5-6, Page 189-197, October–December 2025. Sulfur mustard, a Schedule 1 chemical under the Chemical Weapons Convention (CWC), poses a significant threat to human health, animals, plants, and the environment due to its persistent nature. Bis(2-methoxyethylthio)alkanes (compounds10–14), along with …
- by AI Ivanov, AN Konenkov, NV KonenkovEuropean Journal of Mass Spectrometry, Volume 31, Issue 5-6, Page 139-146, October–December 2025. The ion-optical properties of the second stability region (q=4.5) formed by the square wave shape potential with a duty cycle of 50% are studied as applied to the operation of a linear ion trap. The stability diagram is presented in detail, the stability …
- by Shumaila Yousaf, Sadia Nawaz, Shagufta Saeed, Huma Mujahid, Azamt Ullah, Duaa Qaiser, Tahir MehmoodEuropean Journal of Mass Spectrometry, Volume 31, Issue 5-6, Page 182-188, October–December 2025. Diabetes mellitus (DM) is an onset metabolic illness in which hyperglycemia occurs due to acquired or inherited impaired insulin production and ineffective action. Diabetes is frequently managed with the use of drugs, which may have adverse consequences …
- by Abdulaziz Aljohari, Adham Bahian, Adnan A Kadi, AFM Motiur RahmanDepartment of Pharmaceutical Chemistry, 108788College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaEuropean Journal of Mass Spectrometry, Volume 31, Issue 5-6, Page 169-181, October–December 2025. Chemical modification of the tyrosine kinase inhibitor (TKI) imatinib was performed to obtain the imatinib-N-oxide, followed by metabolic profiling to study the possibilities of forming potential reactive metabolites of both imatinib and imatinib-N-oxide. …
Mass spectrometry websites, social media, journal feeds, and other links and items of interest to the mass spectrometry community.
